Increased expression levels of adiponectin mRNA and its receptor as an insulin sensitivity agent, followed by an enhancement of the pump mRNA levels and PGC‐1α, contribute to glycemic and insulin resistance control. The gene discussed is ADIPOQ; the disease is Insulin resistance.